•
Mar 31, 2021

Welltower Q1 2021 Earnings Report

Welltower's financial performance for Q1 2021 was reported, featuring key strategic moves and operational updates.

Key Takeaways

Welltower reported a net income of $0.17 per diluted share and normalized FFO of $0.80 per diluted share. The company saw an increase in Seniors Housing Operating (SHO) portfolio occupancy and completed significant investments and dispositions, including a substantial exit from its operating relationship with Genesis Healthcare.

Net income attributable to common stockholders was reported at $0.17 per diluted share.

Normalized FFO attributable to common stockholders was reported at $0.80 per diluted share.

SHO portfolio occupancy increased by approximately 60 bps from the pandemic low on March 12, 2021.

Completed $368 million of pro rata gross investments and $216 million in pro rata property dispositions during the quarter.

Total Revenue
$1.05B
Previous year: $1.26B
-16.4%
EPS
$0.8
Previous year: $1.02
-21.6%
Gross Profit
$435M
Previous year: $577M
-24.6%
Cash and Equivalents
$2.13B
Previous year: $303M
+602.6%
Total Assets
$33B
Previous year: $32.9B
+0.2%

Welltower

Welltower

Welltower Revenue by Segment

Forward Guidance

Welltower anticipates net income per share to be between $0.31 and $0.36, and normalized FFO per share to be between $0.72 and $0.77 for the second quarter of 2021.

Positive Outlook

  • Guidance assumes a continuation of recent trends resulting in an approximate increase of 130 bps in SHO Portfolio Occupancy through the second quarter.
  • Full year general and administrative expenses are anticipated to be approximately $135 million to $140 million.
  • Stock-based compensation expense is expected to be approximately $21 million.
  • Second quarter 2021 earnings guidance includes only those acquisitions closed or announced to date.
  • Approximately $320 million of development funding is anticipated in 2021 relating to projects underway on March 31, 2021.

Challenges Ahead

  • The extent to which the COVID-19 pandemic impacts operations depends on future developments, which are highly uncertain.
  • Second quarter guidance does not include the recognition of any Provider Relief Funds which may be received during the quarter.
  • Guidance does not include any additional investments, dispositions or capital transactions beyond those announced.
  • Guidance does not include any other expenses, impairments, unanticipated additions to the loan loss reserve or other additional normalizing items.
  • Expects pro rata disposition proceeds of $1.1 billion at a blended yield of 7.9% in 2021.

Revenue & Expenses

Visualization of income flow from segment revenue to net income